$NBTX

Voting Rights and Shares Capital of the Company

Nanobiotix reported its voting rights as of May 31, 2026: 50,807,903 shares outstanding, with 54,304,858 total theoretical voting rights and 54,282,740 exercisable voting rights. The filing cites French Commercial Code L.233-8 II and AMF rules on gross and net voting-right calculations, relevant for threshold monitoring on Euronext Paris and Nasdaq.

Original reporting
Published Jun 5, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 9:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Voting Rights and Shares Capital of the Company — source image
Decision brief

The 30-second read

$NBTXNeutralLow
01

Why it matters

This updates governance metrics used for threshold crossings; it does not provide new clinical trial results, financing terms, or corporate actions.

02

Market read

Primarily administrative; useful for investors tracking voting-rights thresholds and meeting-related calculations.

03

What to watch

Without accompanying shareholder stake changes or corporate actions, the disclosure is unlikely to drive liquidity or sentiment.

Relevance 4/10Novelty 3/10Timing: as-of May 31 voting-rights update; published June 5

Background

The article is a regulatory disclosure under French Commercial Code/AMF rules reporting total voting rights (theoretical and exercisable) and shares outstanding as of May 31, 2026.

Company-level read

Ticker impact

$NBTXNeutralMedium confidence
Context

Nanobiotix discloses its voting rights and total shares outstanding as of May 31, 2026, a regulatory threshold metric for NBTX.

Expected impact

Low/immaterial near-term; any move would be limited to technical positioning around governance thresholds.

Evidence & confidence

The release is a French/AMF-compliance update of voting rights counts (theoretical vs exercisable) rather than new clinical, financial, or deal information.

Market effects

Minimal; governance/float mechanics are company-specific and do not change sector fundamentals.

Limited to Euronext Paris/Nasdaq cross-listing compliance optics.

Low; primarily affects threshold-tracking and shareholder meeting calculations.

Counterpoint

Traders focused on ownership-threshold triggers could treat this as a check for potential future filings, but the article itself contains no new ownership change.

Key entities

  • Nanobiotix

    Late-stage clinical biotechnology company listed on Euronext Paris and Nasdaq (NBTX).

  • AMF (Autorité des Marchés Financiers)

    French financial markets authority referenced for voting-rights calculation rules.

Related articles

$NBTXHighAI 9/10

NANOBIOTIX Announces Closing of Global Offering

Nanobiotix said it has closed its global offering, including the underwriters’ option for additional shares/ADSs. After full option exercise, it issued 2,218,467 ordinary shares (225,373 ADSs plus 33,805 additional ADSs) and 345,099 pre-funded warrants, raising about $100 million (€86.1 million) gross. Net proceeds will fund JNJ-1900 (<10%), Nanoprimer (50–60%), and general purposes (30–40%).

$COINMed

The CLARITY Act Fails 50 to 49: What’s Next for XRP, Bitcoin, Ethereum, and Solana Now That Congress Is Done for the Year?

The CLARITY Act failed in the Senate with a 49-50 vote, falling short of the 60 needed for passage. XRP dropped 7.98% to $1.29, while Bitcoin fell 1.42% to $75,924. Coinbase and Circle shares declined 8% and 11% respectively. The act's failure leaves regulatory uncertainty for cryptocurrencies, with their values now dependent on SEC initiatives and market conditions.

$HYPE-USDLow

Hyperliquid News: Kraken Parent Eyes First US-Regulated HYPE Perpetuals

Payward, Kraken's parent, plans to offer US-regulated on-chain perpetual futures using Hyperliquid's HIP-3 markets. Bitnomial will create and clear the contracts, while NinjaTrader will manage client accounts. HYPE, Hyperliquid's token, trades near $79.29. Payward reported 6.6 million funded accounts and a proof of reserves exceeding 100%. Nasdaq plans to invest $100 million in Payward, valuing it at $21 billion.

$CACCMedAI 8/10

$373,000 awarded to 260 Washington borrowers from loan settlement with auto lender

Credit Acceptance Corporation (CACC) will pay $694 million to resolve claims of risky loan practices. About 260 Washington residents will receive $373,000 in restitution, with $2.4 million in loan forgiveness. The settlement requires CACC to improve disclosures and protections. The company will provide $388 million in debt relief for repossessed vehicles and $246 million for those still owning their vehicles.

$ACNMed

Accenture Settles DOJ DEI Case For $25M, Denies Wrongdoing

Accenture agreed to pay $25M to settle a DOJ case alleging its federal contractor subsidiary, Accenture Federal Services, considered race or sex in hiring. The company denies wrongdoing and will report Q4 2026 earnings on Oct 1. The DOJ claims AFS violated the False Claims Act by falsely certifying compliance with anti-discrimination laws.

$COINHigh

The SEC Steps In to Ease Crypto’s Path After Big Legislative Loss

The SEC introduced a five-year exemption to securities laws to enable trading of tokenized stocks, following Congress' failure to pass the Clarity Act. This move aims to support digital assets and follows a 48-hour turnaround. Bitcoin and crypto-linked stocks like Coinbase (COIN), Robinhood (HOOD), and Circle (CRCL) saw gains.